Pathophysiological Drivers of Mast Cell Activation Syndrome and Implications for Treatment
Fortune Journal of Health Sciences · 2026 · 9 (3)
DOI: 10.26502/fjhs.427 ↗Kurz gefasst
Fachartikel in der Zeitschrift Fortune Journal of Health Sciences, 2026. Verfasst von Spencer Collins und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Research, College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, California 91766…. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Translational Research, College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, California 91766 USA.
Förderung
- NIAID NIH HHS
Zitieren
APA
Collins, S., Williams, T., Sanchez, E., & Agrawal, D. K. (2026). Pathophysiological Drivers of Mast Cell Activation Syndrome and Implications for Treatment. Fortune Journal of Health Sciences, 9(3). https://doi.org/10.26502/fjhs.427
Vancouver
Collins S, Williams T, Sanchez E, Agrawal DK. Pathophysiological Drivers of Mast Cell Activation Syndrome and Implications for Treatment. Fortune Journal of Health Sciences. 2026;9(3). doi:10.26502/fjhs.427
BibTeX
@article{Collins2026,
author = {Collins, Spencer and Williams, Tyler and Sanchez, Edgar and Agrawal, Devendra K},
title = {Pathophysiological Drivers of Mast Cell Activation Syndrome and Implications for Treatment},
journal = {Fortune Journal of Health Sciences},
year = {2026},
volume = {9},
number = {3},
doi = {10.26502/fjhs.427}
}
EUVIMED